Two legal frameworks, purpose-built for each sector
A biotech founder is considering taking a proven human-health asset into animal health. The science translates and the market potential is real, but the regulatory pathway is different. Since January 2022, veterinary medicines have had their own EU regulatory framework, with a dedicated committee, procedures and decision logic. Understanding these routes early can turn regulatory strategy into a commercial advantage.
In Episode 3, Jean-Luc Troch, Caroline Chauché, and Eric Del Cotto put the human and veterinary frameworks side by side. They explore the veterinary-specific forces with no human equivalent and discuss how choosing the most strategic route can shape cost, geographic footprint and speed to first sale.
Read the full episode →
